News

Upcoming Extraordinary General Meeting for Shareholders of Campine

Upcoming Extraordinary General Meeting for Shareholders of Campine

Invitation to the Extraordinary General Meeting

Campine NV is calling all shareholders to participate in an important extraordinary general meeting. This event is scheduled to take place at 10:30 a.m. at the Hotel Botanique Sanctuary located in Antwerp. Your participation is crucial as we will discuss significant agenda items related to the company's governance and operations.

Meeting Agenda Overview

1. Ratification of Director Resignation

One of the key matters to be discussed is the acknowledgment and ratification of the resignation of the director, “DELOX,” represented by Mr. De Groote Patrick. The extraordinary general meeting will finalize this resignation, allowing for the discharge of their mandate to be addressed in the next annual meeting.

2. Prolongation of Capital Increase Authorization

Another important resolution involves granting a prolongation of the board's authorization to increase the company’s capital by an additional four million euros (€ 4,000,000.00). This authorization would be effective for a period of five years, starting from the publication date of the amendment to the articles of association.

3. Share Buyback Authorization

The meeting will also vote on extending the board's authorization to acquire its own shares for another five years. The board believes this policy will be beneficial for the company and its shareholders.

4. Compensation Amendments

Additionally, the extraordinary meeting will consider amendments to the compensation structure as outlined in article 23 of the articles of association. The board aims to adjust directors' remuneration based on proposals from the remuneration committee, ensuring fair compensation reflecting directors' contributions.

5. Profit Allocation and Reserve Fund Amendments

Amendments to article 39 regarding profit allocation will also be proposed. A minimum of five percent of the net profit will be allocated to forming a reserve fund until it reaches one-tenth of the capital. Shareholders will have a say in the final allocation of profits during the annual meeting.

6. Articles of Association Adjustments

Finally, adjustments to articles 7 and 12 will be proposed to ensure they align with previous agenda points. These adjustments are essential for maintaining compliance with the legal framework governing the company's operations.

Conditions of Admission

To attend the extraordinary general meeting, shareholders must be officially registered by the specified registration date. It’s essential that you confirm your participation by the deadline. Registered shareholders are encouraged to submit their email addresses for efficient communication.

Adding Items to the Agenda

Shareholders holding at least 3% of the share capital have the right to propose additional items for discussion during the meeting. These requests must be submitted to the company in writing by the set deadline.

Submitting Questions

Shareholders may submit questions in writing regarding the agenda items or reports in advance of the meeting. The company is committed to addressing these inquiries during the session, provided they don't compromise any confidential aspects of operations.

Proxy Voting Information

Shareholders wishing to vote by proxy must adhere to registration procedures and designate a representative. This offers shareholders the opportunity to ensure their voice is heard, even if unable to attend in person.

Document Availability

All relevant documents regarding the extraordinary meeting will be made accessible both on the company's website and at the registered office. Shareholders may request copies or consult these documents free of charge.

Frequently Asked Questions

What is the date and time of the extraordinary general meeting?

The meeting is set for Wednesday, 28 May 2025, at 10:30 a.m.

Where will the meeting take place?

The extraordinary general meeting will be held at Hotel Botanique Sanctuary in Antwerp.

Who can attend the meeting?

Only registered shareholders on the specified date are permitted to attend the meeting.

Can shareholders propose additional agenda items?

Yes, shareholders with at least 3% of the capital may add items to the agenda by submitting requests by the designated deadline.

How can shareholders submit questions prior to the meeting?

Shareholders may submit questions in writing or via email before the meeting, which will be addressed during the session.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Crystal Risotti: Leading IT Compliance in Healthcare

Updated Category News Views 1

A Journey Marked by Dedication and Expertise In the demanding world of healthcare technology, where regulations can make or break a company, Crystal Risotti has carved out a space for herself as a leader. Over the last 30 years, she's developed a reputation for blending regulatory expertise with practical business strategies. Her recognition as a Pinnacle Professional of...

Continue Reading
K-9 Hero Act Aims to Ease Costs for Retired Dogs' Care

Updated Category News Views 7

Let's Talk About the Loyalty that Dogs Deserve Who would've thought we'd be chatting about our four-legged heroes in a federal setting? But here we are, giving well-deserved attention to those furry federal agents. They're the ones who sniff out bombs and tackle crooks, and they're not asking for a retirement plan with a yacht – just some vet care! What the K-9 Hero Act...

Continue Reading
Navigating Land Access: The Hidden Roadblock in Mining

Updated Category News Views 2

Mining's Often Overlooked Obstacle: Land Access In the world of mining, the shallow thrills of striking gold are often overshadowed by the frustrating slog of securing land access. You can have your permits lined up, your finances sorted, and drills humming along, but if you haven’t sweet-talked the folks farming above your visible vein of riches, you could be staring...

Continue Reading
Helio Fred Garcia Honored by Diversity Action Alliance

Updated Category News Views 4

Award Ceremony Set in the Big Apple In an industry where recognition often feels as transient as a ticker's daily high, the Diversity Action Alliance (DAA) is doing its bit to emphasize the lasting impact individuals can make. On September 16 in New York City, Helio Fred Garcia will be honored with the 2026 Pat Ford Larger Than Life Impact Award at the DAA's Annual...

Continue Reading
Seismic Pharma Kicks Off Phase 3 Trial for Istaroxime

Updated Category News Views 1

Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...

Continue Reading
Bitwise Pulls Plug on Dogecoin ETF Amid Market Risks

Updated Category News Views 4

Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...

Continue Reading
AI Trust in Finance: Survey Reveals Market Impact

Updated Category News Views 2

Trust in AI for Financial Guidance: Where Are We Headed? The market winds shift with every sunrise, and today’s buzzword? Artificial Intelligence. You’d almost think AI’s trying to steal my job along with every other trader’s mojo. But here's the twist—A survey from Possible Finance shows about 15% of folks would actually lean on AI for their financial advice....

Continue Reading
Liberty Hill: 50 Years of Grassroots Revolution

Updated Category News Views 3

Half a Century of Community Empowerment You don't see organizations sticking to their guns for fifty years without having something real to offer. Liberty Hill Foundation is celebrating this colossal milestone in style by throwing their weight behind 17 grassroots groups under the 2026 Fund for Change. They're not just tossing money around but are genuinely becoming the...

Continue Reading
Flex Dental Solutions Adds BNPL, Surcharging to FlexPayments

Updated Category News Views 2

Diving into Dental Finances: A New Moneymaker? It's about time someone shook up the dental payment scene, and Flex Dental Solutions seems to be the one doing it. They rolled out some intriguing new features for their FlexPayments platform aimed squarely at dental practices using Open Dental. What we're seeing here is their attempt to bridge a couple of financial headaches...

Continue Reading
SES Sells to AFC Industries: A Strategic M&A Move

Updated Category News Views 0

Nashville's Notable Deal in Industrial Supply On a muggy September day in Nashville, XLCS Partners announced it was at the helm of a noteworthy transaction—the sale of Signature Engineered Solutions (SES) to AFC Industries. Now, this isn't just another corporate shuffle; it's a calculated move in the gritty world of fastening and engineered solutions. The Nitty-Gritty...

Continue Reading

Top 5 Most Recently Viewed Articles

Dynavax Encourages Support for Director Nominees Amid Changes

Updated Category News Views 112

Dynavax Urges Stockholders to Support Director Nominees Dynavax's Strategy is Delivering Significant Long-Term Stockholder Value Dynavax's Nominees Are Vastly Superior to Competitors' Candidates Across Every Critical Area Follow Recommendations of Proxy Advisory Firms and Vote "FOR" All Four of Dynavax's Director Nominees on the GOLD Proxy Card Today Dynavax Technologies...

Continue Reading
ION Achieves Landmark Certification for Algorithmic Trading

Updated Category News Views 171

ION Achieves Major Certification for Trading Software Globally recognized leader in trading technology, ION, has successfully secured certification as an Independent Software Vendor for algorithmic trading on BSE. This groundbreaking registration allows exchange members to leverage the advanced trading capabilities of ION's Fidessa trading platform, marking a pivotal step...

Continue Reading
ImmuCell Corporation Updates Lease and By-Laws: Key Insights

Updated Category News Views 128

ImmuCell Corporation Updates Lease Agreement and By-Laws ImmuCell Corporation (NASDAQ:ICCC) has embarked on a series of significant changes recently, including modifying the terms of its lease for the facility located in Portland, Maine. The company also took this opportunity to update its corporate by-laws, as revealed in a filing with the SEC. Revised Lease Agreement On...

Continue Reading
Navigating the Future of Zscaler: Options Insight and Performance

Updated Category News Views 157

Insights into Zscaler's Options Market Activity Recently, significant market players have exhibited a noticeably cautious outlook regarding Zscaler. The analysis of Zscaler's options history reveals intriguing patterns that might influence future trading decisions. Understanding the Options Trades In our examinations of the options trades associated with Zscaler (NASDAQ:...

Continue Reading
BPGbio Teams with Oxford University to Propel Protein Research Forward

Updated Category News Views 107

BPGbio and University of Oxford Collaborate on Groundbreaking Research BPGbio, Inc., a prominent, AI-driven clinical-stage biopharmaceutical company focusing on innovative mitochondrial biology and protein homeostasis, has officially entered into a strategic collaboration with the University of Oxford. This partnership aims to push the frontiers of research in protein...

Continue Reading